Paradigm Biopharmaceuticals Limited (ASX:PAR)
0.2800
+0.0150 (5.66%)
Sep 5, 2025, 4:10 PM AEST
ASX:PAR Market Cap
ASX:PAR has a market cap or net worth of 111.28 million as of September 5, 2025. Its market cap has increased by 38.09% in one year.
Market Cap
111.28M
Enterprise Value
86.68M
Revenue
16.70K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.28
Market Cap Chart
Since August 19, 2015, ASX:PAR's market cap has increased from 32.40M to 111.28M, an increase of 243.41%. That is a compound annual growth rate of 13.05%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 5, 2025 | 111.28M | -23.80% |
Dec 31, 2024 | 146.04M | -2.24% |
Dec 29, 2023 | 149.39M | -62.33% |
Dec 30, 2022 | 396.54M | -8.38% |
Dec 31, 2021 | 432.81M | -25.94% |
Dec 31, 2020 | 584.38M | 1.29% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 100.05B |
Pro Medicus | 30.39B |
Cochlear | 19.36B |
Sonic Healthcare | 11.24B |
Ramsay Health Care | 7.78B |
Ansell | 4.99B |
Telix Pharmaceuticals | 4.79B |
Mesoblast | 2.48B |